Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Transfusion Medicine (Oxford, England)
|
October 6, 2005
The age of stored red blood cell concentrates at the time of transfusion
N J H Raat, F Berends, A J Verhoeven, et al.
Biosensors & Bioelectronics
|
July 20, 2012
Development of a novel liquid crystal based cell traction force transducer system
C F Soon, M Youseffi, R F Berends, et al.
IARC Scientific Publications
|
January 1, 1986
Interactions of the antitumour drug cisplatin with DNA in vitro and in vivo
A M Fichtinger-Schepman, P H Lohman, F Berends, et al.
Mutation Research
|
November 1, 1985
Kinetics of unscheduled DNA synthesis in UV-irradiated chicken embryo fibroblasts
L Roza, M H Wade, G P van der Schans, et al.
Mutation Research
|
December 1, 1987
DNA methods for detecting and analyzing mutations in vivo
P H Lohman, J Vijg, A G Uitterlinden, et al.
Clinical Chemistry
|
October 1, 1988
Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma
J A Hoek, A Sturk, J W ten Cate, et al.
Mutation Research
|
April 1, 1981
Mutagenicity testing of dichloromethane in short-term mammalian tests systems
W M Jongen, P H Lohman, M J Kottenhagen, et al.
IARC Scientific Publications
|
January 1, 1988
Induction and removal of cisplatin-DNA adducts in human cells in vivo and in vitro as measured by immunochemical techniques
A M Fichtinger-Schepman, F J Dijt, P Bedford, et al.
Thrombosis and Haemostasis
|
March 11, 1998
Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects
E de Jonge, M Levi, F Berends, et al.
Carcinogenesis
|
October 1, 1995
Cisplatin- and carboplatin-DNA adducts: is PT-AG the cytotoxic lesion?
A M Fichtinger-Schepman, H C van Dijk-Knijnenburg, S D van der Velde-Visser, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Transfusion Medicine (Oxford, England)
|
October 6, 2005
The age of stored red blood cell concentrates at the time of transfusion
N J H Raat, F Berends, A J Verhoeven, et al.
Biosensors & Bioelectronics
|
July 20, 2012
Development of a novel liquid crystal based cell traction force transducer system
C F Soon, M Youseffi, R F Berends, et al.
IARC Scientific Publications
|
January 1, 1986
Interactions of the antitumour drug cisplatin with DNA in vitro and in vivo
A M Fichtinger-Schepman, P H Lohman, F Berends, et al.
Mutation Research
|
November 1, 1985
Kinetics of unscheduled DNA synthesis in UV-irradiated chicken embryo fibroblasts
L Roza, M H Wade, G P van der Schans, et al.
Mutation Research
|
December 1, 1987
DNA methods for detecting and analyzing mutations in vivo
P H Lohman, J Vijg, A G Uitterlinden, et al.
Clinical Chemistry
|
October 1, 1988
Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma
J A Hoek, A Sturk, J W ten Cate, et al.
Mutation Research
|
April 1, 1981
Mutagenicity testing of dichloromethane in short-term mammalian tests systems
W M Jongen, P H Lohman, M J Kottenhagen, et al.
IARC Scientific Publications
|
January 1, 1988
Induction and removal of cisplatin-DNA adducts in human cells in vivo and in vitro as measured by immunochemical techniques
A M Fichtinger-Schepman, F J Dijt, P Bedford, et al.
Thrombosis and Haemostasis
|
March 11, 1998
Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects
E de Jonge, M Levi, F Berends, et al.
Carcinogenesis
|
October 1, 1995
Cisplatin- and carboplatin-DNA adducts: is PT-AG the cytotoxic lesion?
A M Fichtinger-Schepman, H C van Dijk-Knijnenburg, S D van der Velde-Visser, et al.
Page
of 6